Vericel Corp.
-
Financial
Vericel Reports First Quarter 2019 Financial Results and Raises Full Year 2019 Revenue Guidance
CAMBRIDGE, Mass., May 07, 2019 (GLOBE NEWSWIRE) — Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell therapies for the sports…
Read More » -
Financial
Vericel Reports Record Third Quarter Revenues of $22.5 Million and Raises Full Year 2018 Revenue Guidance
CAMBRIDGE, Mass., Nov. 06, 2018 (GLOBE NEWSWIRE) — Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell therapies for the sports…
Read More » -
Financial
Vericel Reports First Quarter 2018 Financial Results
CAMBRIDGE, Mass., May 08, 2018 (GLOBE NEWSWIRE) — Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn…
Read More »